Albiges L - Search Results

1

False positive 2-(18)Fluroro-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with disseminated seminoma and post-chemotherapy residual masses.

Wagner M, Bellmunt J, Boutros C, Bonardel G, Loriot Y, Albiges L, Massard C, Fizazi K. Wagner M, et al. Among authors: albiges l. Clin Genitourin Cancer. 2013 Mar;11(1):66-9. doi: 10.1016/j.clgc.2012.06.006. Epub 2012 Sep 13. Clin Genitourin Cancer. 2013. PMID: 22981209 No abstract available.

2

[New drugs in metastatic castration-resistant prostate cancer].

Albiges L, Loriot Y, Gross-Goupil M, de La Motte Rouge T, Blesius A, Escudier B, Massard C, Fizazi K. Albiges L, et al. Bull Cancer. 2010 Jan;97(1):149-59. doi: 10.1684/bdc.2009.1023. Bull Cancer. 2010. PMID: 20022854 French.

3

How to select targeted therapy in renal cell cancer.

Escudier B, Albiges L, Blesius A, Loriot Y, Massard C, Fizazi K. Escudier B, et al. Among authors: albiges l. Ann Oncol. 2010 Oct;21 Suppl 7:vii59-62. doi: 10.1093/annonc/mdq371. Ann Oncol. 2010. PMID: 20943644 Free article. Review.

4

[Kikuchi disease and lupus: case report, literature review and FDG PET/CT interest].

Abraham M, Lazareth I, Bonardel G, Albiges L, Dechaud C, Marini V, Michon-Pasturel U, Molinier V, Priollet P. Abraham M, et al. Among authors: albiges l. J Mal Vasc. 2011 Jul;36(4):274-9. doi: 10.1016/j.jmv.2011.05.004. Epub 2011 Jul 14. J Mal Vasc. 2011. PMID: 21757306 Review. French.

5

Accelerated MVAC chemotherapy in patients with advanced bladder cancer previously treated with a platinum-gemcitabine regimen.

Edeline J, Loriot Y, Culine S, Massard C, Albiges L, Blesius A, Escudier B, Fizazi K. Edeline J, et al. Among authors: albiges l. Eur J Cancer. 2012 May;48(8):1141-6. doi: 10.1016/j.ejca.2012.01.022. Epub 2012 Feb 22. Eur J Cancer. 2012. PMID: 22364733

6

Novel and bone-targeted agents for CRPC.

Fizazi K, Albiges L, Massard C, Escudier B, Loriot Y. Fizazi K, et al. Among authors: albiges l. Ann Oncol. 2012 Sep;23 Suppl 10:x264-7. doi: 10.1093/annonc/mds353. Ann Oncol. 2012. PMID: 22987974 Free article.

7

How to select amongst available options for the treatment of advanced RCC?

Escudier B, Albiges L, Massard C, Loriot Y, Fizazi K. Escudier B, et al. Among authors: albiges l. Ann Oncol. 2012 Sep;23 Suppl 10:x309-12. doi: 10.1093/annonc/mds352. Ann Oncol. 2012. PMID: 22987982 Free article.

8

Second line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients.

Levy A, Menard J, Albiges L, Loriot Y, Di Palma M, Fizazi K, Escudier B. Levy A, et al. Among authors: albiges l. Eur J Cancer. 2013 May;49(8):1898-904. doi: 10.1016/j.ejca.2013.02.003. Epub 2013 Mar 13. Eur J Cancer. 2013. PMID: 23490648

9

Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100).

Loriot Y, Bianchini D, Ileana E, Sandhu S, Patrikidou A, Pezaro C, Albiges L, Attard G, Fizazi K, De Bono JS, Massard C. Loriot Y, et al. Among authors: albiges l. Ann Oncol. 2013 Jul;24(7):1807-1812. doi: 10.1093/annonc/mdt136. Epub 2013 Apr 10. Ann Oncol. 2013. PMID: 23576708 Free article.

10

Clinical benefit for patients with non-small cell lung cancer enrolled in phase I trials.

Levy A, Gomez-Roca C, Massard C, Planchard D, Albiges L, Bahleda R, Bourgier C, Deutsch E, Soria JC, Besse B. Levy A, et al. Among authors: albiges l. Onkologie. 2013;36(6):357-62. doi: 10.1159/000351257. Epub 2013 May 13. Onkologie. 2013. PMID: 23774150 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters